Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-06-27 | 2022-09-06 | 163445 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2022-08-12 | 2022-09-02 | 166607 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-01-13 | 179450 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2023-09-01 | 2023-09-07 | 203539 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-01-05 | 2024-02-16 | 215218 |
| APO-FLAVOXATE | 200MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19117 |
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216744 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2017-06-19 | 2017-07-19 | 13317 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-04-04 | 2019-08-02 | 80533 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-09-12 | 2019-10-01 | 93671 |
| APO-FINASTERIDE | 5MG | TABLET | Actual shortage | 2024-01-19 | 2024-02-16 | 216684 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-08-08 | 2017-09-22 | 18543 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-08-01 | 55299 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-16 | 2019-11-18 | 96647 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-06 | 2020-09-04 | 121903 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-26 | 2020-09-02 | 122994 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-23 | 2023-03-02 | 179444 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-23 | 2023-03-02 | 179447 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |